Company Search:
Advanced Search
Sponsored Links
Cogstate Ltd Company Snapshot
Cogstate Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cogstate Ltd with three other companies in this sector in AUSTRALIA : Clinuvel Pharmaceuticals Limited (2021 sales of 48.32 million Australian Dollars [US$35.22 million] of which 100% was Biotechnology), Pharmaxis Ltd (22.85 million Australian Dollars [US$16.65 million] of which 99% was Mannitol), and Idt Australia Limited. (16.93 million Australian Dollars [US$12.34 million] ).

Sales Analysis. During the year ended June of 2021, sales at Cogstate Ltd were A$43.77 million (US$31.90 million). This is an increase of 23.8% versus 2020, when the company's sales were A$35.36 million. Sales of Healthcare Market saw an increase of 43.4% in 2021, from A$3.51 million to A$5.03 million. Not all segments of Cogstate Ltd experienced an increase in sales in 2021: sales of Research fell 10.2% to A$347,890.41 . (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cogstate Ltd
  Stock Performance Chart for Cogstate Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): 2.10
(Figures in Australian Dollars)
1 Week 20.3%   13 Weeks 34.6%  
4 Weeks 59.1%   52 Weeks 220.6%  
Cogstate Ltd Key Data:
  Ticker: CGS Country: Australia
  Exchanges: OTC BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 43,766,348
(Year Ending Jan 2022).
Employees: 61
  Currency: Australian Dollars Market Cap: 359,075,495
  Fiscal Yr Ends: June Shares Outstanding: 170,988,331
  Share Type: Ordinary Closely Held Shares: 91,804,345
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.